Live from the NIH registry
Studies recruiting near Palmdale right now
Top 25 of 129 recruiting studies, sorted by proximity — each links to its official registry page
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Om Research LLC — Lancaster, California (7.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Lancaster, California (7.4 mi)
· Sponsor: Akero Therapeutics, Inc
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Lancaster, California (7.4 mi)
· Sponsor: GlaxoSmithKline
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Om Research LLC — Lancaster, California (7.4 mi)
· Sponsor: Eli Lilly and Company
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Overweight
Phase 3
Interventional 400 participants sought
First Valley Medical Group — Lancaster, California (7.4 mi)
· Sponsor: Novo Nordisk A/S
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Vitiligo, Non-Segmental Vitiligo (NSV)
Phase 2
Interventional 66 participants sought
Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway — Santa Clarita, California (28.6 mi)
· Sponsor: Eli Lilly and Company
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
Olive View UCLA Medical Center — Sylmar, California (27.8 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 600 participants sought
Gastro Care Associates — Lancaster, California (7.4 mi)
· Sponsor: Hoffmann-La Roche
Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
End-Stage Renal Disease
N/A
Observational 100 participants sought
Olive View - UCLA Medical Center — Sylmar, California (27.8 mi)
· Sponsor: LifeNet Health
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: National Cancer Institute (NCI)
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 19 — Palmdale, California (1.2 mi)
· Sponsor: BioStem Technologies
Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference
Colonic Polyps
N/A
Interventional 330 participants sought
Gastro Care Institute — Lancaster, California (7.4 mi)
· Sponsor: Capso Vision, Inc.
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
San Fernando — San Fernando, California (28.8 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Lancaster, California (7.4 mi)
· Sponsor: GlaxoSmithKline
Aveir VR Coverage With Evidence Development Post-Approval Study
Cardiac Pacemaker, Arrythmia
N/A
Observational 8,744 participants sought
Abbott — Sylmar, California (27.8 mi)
· Sponsor: Abbott Medical Devices
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 425 participants sought
Om Research LLC — Lancaster, California (7.4 mi)
· Sponsor: Hoffmann-La Roche
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Severe Asthma
Phase 2
Interventional 512 participants sought
Research site — Lancaster, California (7.4 mi)
· Sponsor: Kinaset Therapeutics Inc
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma
Phase 2
Interventional 227 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Tujunga, California (25.8 mi)
· Sponsor: GlaxoSmithKline
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Irritable Bowel Syndrome, Constipation
Phase 2
Interventional 342 participants sought
Om Research LLC — Lancaster, California (7.4 mi)
· Sponsor: Eli Lilly and Company
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
Om Research — Lancaster, California (7.4 mi)
· Sponsor: Eccogene
Aveir DR Real-World Evidence Post-Approval Study
Cardiac Pacemaker, Arrythmia
N/A
Observational 1,805 participants sought
Abbott — Sylmar, California (27.8 mi)
· Sponsor: Abbott Medical Devices
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Asthma
Phase 2
Interventional 252 participants sought
Antelope Valley Clinical Trials — Lancaster, California (7.4 mi)
· Sponsor: Pfizer